Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | 19.18% |
| Q3 2025 | -8.53% |
| Q2 2025 | -2.62% |
| Q1 2025 | -7.69% |
| Q4 2024 | 44.85% |
| Q3 2024 | -20.57% |
| Q2 2024 | 24.40% |
| Q1 2024 | -19.48% |
| Q4 2023 | -15.00% |
| Q3 2023 | -14.30% |
| Q2 2023 | -12.49% |
| Q1 2023 | -11.03% |
| Q4 2022 | -10.88% |
| Q3 2022 | -3.76% |
| Q2 2022 | -7.46% |
| Q1 2022 | -7.45% |
| Q4 2021 | -5.90% |
| Q3 2021 | 3.54% |
| Q2 2021 | 644.31% |
| Q1 2021 | 36.43% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |